| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR5P2 ADGRG5 OR2B2 OR2T27 F2RL3 OR9I1 OR13C3 OR13C4 ADGRV1 OR14C36 OR2T10 OR2T34 GRM1 S1PR1 OR14A16 OR8B3 OR2T3 OR2K2 ADRA2A OR13A1 MRGPRG OR8B2 | 2.84e-10 | 884 | 99 | 22 | GO:0004930 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | OR5P2 ADGRG5 OR2B2 OR2T27 F2RL3 OR9I1 OR13C3 C17orf99 OR13C4 SOSTDC1 ADGRV1 OR14C36 OR2T10 OR2T34 GRM1 S1PR1 OR14A16 OR8B3 OR2T3 OR2K2 ADRA2A OR13A1 MRGPRG OR8B2 UNC5D PLXNA1 | 1.34e-09 | 1353 | 99 | 26 | GO:0004888 |
| GeneOntologyMolecularFunction | olfactory receptor activity | OR5P2 OR2B2 OR2T27 OR9I1 OR13C3 OR13C4 OR14C36 OR2T10 OR2T34 OR14A16 OR8B3 OR2T3 OR2K2 OR13A1 OR8B2 | 3.32e-09 | 431 | 99 | 15 | GO:0004984 |
| GeneOntologyMolecularFunction | alpha-1B adrenergic receptor binding | 1.18e-07 | 3 | 99 | 3 | GO:0031692 | |
| GeneOntologyMolecularFunction | odorant binding | 3.27e-06 | 127 | 99 | 7 | GO:0005549 | |
| GeneOntologyMolecularFunction | adrenergic receptor binding | 5.60e-06 | 24 | 99 | 4 | GO:0031690 | |
| GeneOntologyMolecularFunction | alpha-1A adrenergic receptor binding | 2.43e-05 | 2 | 99 | 2 | GO:0031691 | |
| GeneOntologyMolecularFunction | follicle-stimulating hormone receptor binding | 7.28e-05 | 3 | 99 | 2 | GO:0031762 | |
| GeneOntologyMolecularFunction | angiotensin receptor binding | 1.07e-03 | 10 | 99 | 2 | GO:0031701 | |
| GeneOntologyMolecularFunction | thioesterase binding | 1.07e-03 | 10 | 99 | 2 | GO:0031996 | |
| GeneOntologyMolecularFunction | arrestin family protein binding | 1.55e-03 | 12 | 99 | 2 | GO:1990763 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | OR5P2 ADGRG5 OR2B2 OR2T27 F2RL3 OR9I1 OR13C3 OR13C4 ADGRV1 OR14C36 OR2T10 OR2T34 GRM1 S1PR1 OR14A16 GSK3A OR8B3 OR2T3 OR2K2 ADRA2A ARRB1 ARRB2 OR13A1 MRGPRG AKAP13 OR8B2 CDC42 DNM2 PLCE1 | 2.46e-12 | 1395 | 95 | 29 | GO:0007186 |
| GeneOntologyBiologicalProcess | detection of stimulus | OR5P2 OR2B2 OR2T27 OR9I1 OR13C3 OR13C4 ADGRV1 OR14C36 OR2T10 OR2T34 PKD1L2 OR14A16 OR8B3 OR2T3 OR2K2 ARRB1 ARRB2 OR13A1 OR8B2 | 6.40e-10 | 722 | 95 | 19 | GO:0051606 |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR5P2 OR2B2 OR2T27 OR9I1 OR13C3 OR13C4 ADGRV1 OR14C36 OR2T10 OR2T34 OR14A16 OR8B3 OR2T3 OR2K2 ARRB2 OR13A1 OR8B2 | 1.20e-09 | 582 | 95 | 17 | GO:0050906 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | OR5P2 OR2B2 OR2T27 OR9I1 OR13C3 OR13C4 OR14C36 OR2T10 OR2T34 OR14A16 OR8B3 OR2T3 OR2K2 OR13A1 OR8B2 | 1.23e-09 | 432 | 95 | 15 | GO:0050911 |
| GeneOntologyBiologicalProcess | sensory perception of smell | OR5P2 OR2B2 OR2T27 OR9I1 OR13C3 OR13C4 OR14C36 OR2T10 OR2T34 OR14A16 OR8B3 OR2T3 OR2K2 OR13A1 OR8B2 | 3.34e-09 | 465 | 95 | 15 | GO:0007608 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR5P2 OR2B2 OR2T27 OR9I1 OR13C3 OR13C4 OR14C36 OR2T10 OR2T34 OR14A16 OR8B3 OR2T3 OR2K2 OR13A1 OR8B2 | 5.90e-09 | 485 | 95 | 15 | GO:0050907 |
| GeneOntologyBiologicalProcess | sensory perception | OR5P2 OR2B2 OR2T27 OR9I1 OR13C3 OR13C4 ADGRV1 OR14C36 OR2T10 OR2T34 GRM1 TECTA OR14A16 OR8B3 OR2T3 OR2K2 ADRA2A ARRB1 ARRB2 OR13A1 OR8B2 | 1.37e-08 | 1072 | 95 | 21 | GO:0007600 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR5P2 OR2B2 OR2T27 OR9I1 OR13C3 OR13C4 OR14C36 OR2T10 OR2T34 OR14A16 OR8B3 OR2T3 OR2K2 OR13A1 OR8B2 | 1.66e-08 | 524 | 95 | 15 | GO:0009593 |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | OR5P2 OR2B2 OR2T27 OR9I1 OR13C3 OR13C4 OR14C36 OR2T10 OR2T34 OR14A16 OR8B3 OR2T3 OR2K2 OR13A1 OR8B2 | 2.92e-08 | 547 | 95 | 15 | GO:0007606 |
| GeneOntologyBiologicalProcess | small GTPase-mediated signal transduction | F2RL3 RALGAPB USP8 ADRA2A ARRB1 SSX2IP AKAP13 CDC42 DNM2 CDON PLCE1 | 3.71e-05 | 538 | 95 | 11 | GO:0007264 |
| GeneOntologyBiologicalProcess | G protein-coupled receptor internalization | 1.19e-04 | 21 | 95 | 3 | GO:0002031 | |
| GeneOntologyBiologicalProcess | regulation of protein catabolic process at postsynapse, modulating synaptic transmission | 2.08e-04 | 5 | 95 | 2 | GO:0099576 | |
| GeneOntologyCellularComponent | neuron spine | 2.14e-05 | 247 | 98 | 8 | GO:0044309 | |
| GeneOntologyCellularComponent | dendritic spine | 1.44e-04 | 242 | 98 | 7 | GO:0043197 | |
| GeneOntologyCellularComponent | glutamatergic synapse | NPTX1 GRM1 NEDD4 USP8 ADRA2A ARRB2 CNTNAP2 DIXDC1 CDC42 ATP2B1 PLXNA1 DNM2 | 4.36e-04 | 817 | 98 | 12 | GO:0098978 |
| Domain | GPCR_Rhodpsn_7TM | OR5P2 OR2B2 OR2T27 F2RL3 OR9I1 OR13C3 OR13C4 OR14C36 OR2T10 OR2T34 S1PR1 OR14A16 OR8B3 OR2T3 OR2K2 ADRA2A OR13A1 MRGPRG OR8B2 | 9.45e-10 | 670 | 95 | 19 | IPR017452 |
| Domain | 7tm_1 | OR5P2 OR2B2 OR2T27 F2RL3 OR9I1 OR13C3 OR13C4 OR14C36 OR2T10 OR2T34 S1PR1 OR14A16 OR8B3 OR2T3 OR2K2 ADRA2A OR13A1 MRGPRG OR8B2 | 1.12e-09 | 677 | 95 | 19 | PF00001 |
| Domain | Olfact_rcpt | OR5P2 OR2B2 OR2T27 OR9I1 OR13C3 OR13C4 OR14C36 OR2T10 OR2T34 OR14A16 OR8B3 OR2T3 OR2K2 OR13A1 OR8B2 | 1.28e-09 | 393 | 95 | 15 | IPR000725 |
| Domain | G_PROTEIN_RECEP_F1_1 | OR5P2 OR2B2 OR2T27 F2RL3 OR9I1 OR13C3 OR13C4 OR14C36 OR2T10 OR2T34 S1PR1 OR14A16 OR8B3 OR2T3 OR2K2 ADRA2A OR13A1 MRGPRG OR8B2 | 1.36e-09 | 685 | 95 | 19 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | OR5P2 OR2B2 OR2T27 F2RL3 OR9I1 OR13C3 OR13C4 OR14C36 OR2T10 OR2T34 S1PR1 OR14A16 OR8B3 OR2T3 OR2K2 ADRA2A OR13A1 MRGPRG OR8B2 | 1.57e-09 | 691 | 95 | 19 | PS50262 |
| Domain | GPCR_Rhodpsn | OR5P2 OR2B2 OR2T27 F2RL3 OR9I1 OR13C3 OR13C4 OR14C36 OR2T10 OR2T34 S1PR1 OR14A16 OR8B3 OR2T3 OR2K2 ADRA2A OR13A1 MRGPRG OR8B2 | 1.61e-09 | 692 | 95 | 19 | IPR000276 |
| Domain | Arrestin_N | 1.53e-04 | 4 | 95 | 2 | IPR014753 | |
| Domain | Arrestin | 1.53e-04 | 4 | 95 | 2 | IPR000698 | |
| Domain | - | 1.53e-04 | 4 | 95 | 2 | 2.60.40.840 | |
| Domain | Arrestin_CS | 1.53e-04 | 4 | 95 | 2 | IPR017864 | |
| Domain | ARRESTINS | 1.53e-04 | 4 | 95 | 2 | PS00295 | |
| Domain | - | 5.29e-04 | 7 | 95 | 2 | 2.60.40.640 | |
| Domain | GPS | 6.80e-04 | 34 | 95 | 3 | SM00303 | |
| Domain | Calx_beta | 7.03e-04 | 8 | 95 | 2 | SM00237 | |
| Domain | Arrestin_C | 7.03e-04 | 8 | 95 | 2 | IPR014752 | |
| Domain | GPS | 7.42e-04 | 35 | 95 | 3 | PF01825 | |
| Domain | GPS | 8.06e-04 | 36 | 95 | 3 | PS50221 | |
| Domain | GPS | 8.74e-04 | 37 | 95 | 3 | IPR000203 | |
| Domain | Calx_beta | 9.00e-04 | 9 | 95 | 2 | IPR003644 | |
| Domain | Calx-beta | 9.00e-04 | 9 | 95 | 2 | PF03160 | |
| Domain | Arrestin-like_N | 1.12e-03 | 10 | 95 | 2 | IPR011021 | |
| Domain | Arrestin_C-like | 1.12e-03 | 10 | 95 | 2 | IPR011022 | |
| Domain | Arrestin_C | 1.12e-03 | 10 | 95 | 2 | PF02752 | |
| Domain | Arrestin_N | 1.12e-03 | 10 | 95 | 2 | PF00339 | |
| Domain | Arrestin_C | 1.12e-03 | 10 | 95 | 2 | SM01017 | |
| Domain | 7TM_GPCR_Srsx | 2.57e-03 | 112 | 95 | 4 | SM01381 | |
| Domain | PI3/4_kinase_CS | 2.57e-03 | 15 | 95 | 2 | IPR018936 | |
| Domain | - | 2.93e-03 | 16 | 95 | 2 | 1.10.1070.11 | |
| Domain | PI3Kc | 2.93e-03 | 16 | 95 | 2 | SM00146 | |
| Domain | HEAT_type_2 | 3.31e-03 | 17 | 95 | 2 | IPR021133 | |
| Domain | PI3/4_kinase_cat_dom | 3.71e-03 | 18 | 95 | 2 | IPR000403 | |
| Domain | PI3_PI4_kinase | 3.71e-03 | 18 | 95 | 2 | PF00454 | |
| Domain | PI3_4_KINASE_3 | 3.71e-03 | 18 | 95 | 2 | PS50290 | |
| Domain | PI3_4_KINASE_1 | 3.71e-03 | 18 | 95 | 2 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 3.71e-03 | 18 | 95 | 2 | PS00916 | |
| Domain | USP_CS | 4.63e-03 | 66 | 95 | 3 | IPR018200 | |
| Domain | HEAT_REPEAT | 5.46e-03 | 70 | 95 | 3 | PS50077 | |
| Domain | USP_1 | 5.46e-03 | 70 | 95 | 3 | PS00972 | |
| Domain | UCH | 5.68e-03 | 71 | 95 | 3 | PF00443 | |
| Domain | USP_2 | 5.68e-03 | 71 | 95 | 3 | PS00973 | |
| Domain | USP_3 | 5.90e-03 | 72 | 95 | 3 | PS50235 | |
| Domain | USP_dom | 5.90e-03 | 72 | 95 | 3 | IPR028889 | |
| Domain | Peptidase_C19_UCH | 5.90e-03 | 72 | 95 | 3 | IPR001394 | |
| Domain | C2 | 5.98e-03 | 142 | 95 | 4 | PS50004 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | OR5P2 OR2B2 OR2T27 OR9I1 OR13C3 OR13C4 OR14C36 OR2T10 OR2T34 OR14A16 OR8B3 OR2T3 OR2K2 OR13A1 OR8B2 | 5.97e-09 | 417 | 77 | 15 | M4072 |
| Pathway | KEGG_OLFACTORY_TRANSDUCTION | OR5P2 OR2B2 OR2T27 OR9I1 OR13C3 OR13C4 OR14C36 OR2T10 OR2T34 OR14A16 OR2T3 OR2K2 ARRB2 OR13A1 | 2.03e-08 | 389 | 77 | 14 | M14091 |
| Pathway | REACTOME_SENSORY_PERCEPTION | OR5P2 OR2B2 OR2T27 OR9I1 OR13C3 OR13C4 OR14C36 OR2T10 OR2T34 GRM1 OR14A16 OR8B3 OR2T3 OR2K2 OR13A1 OR8B2 ATP2B1 | 4.19e-08 | 636 | 77 | 17 | M41834 |
| Pathway | REACTOME_ACTIVATION_OF_SMO | 5.46e-05 | 14 | 77 | 3 | MM15228 | |
| Pathway | REACTOME_ACTIVATION_OF_SMO | 1.21e-04 | 18 | 77 | 3 | M27500 | |
| Pubmed | OR5P2 OR2B2 OR2T27 OR9I1 OR13C3 OR13C4 OR14C36 OR2T10 OR2T34 OR14A16 OR8B3 OR2K2 OR13A1 OR8B2 | 4.66e-10 | 541 | 99 | 14 | 14983052 | |
| Pubmed | 2.24e-08 | 3 | 99 | 3 | 11723231 | ||
| Pubmed | 4.45e-07 | 6 | 99 | 3 | 23208550 | ||
| Pubmed | 4.45e-07 | 6 | 99 | 3 | 18544533 | ||
| Pubmed | Different evolutionary processes shaped the mouse and human olfactory receptor gene families. | 5.87e-07 | 340 | 99 | 9 | 11875048 | |
| Pubmed | 5.87e-07 | 340 | 99 | 9 | 11802173 | ||
| Pubmed | 6.31e-07 | 343 | 99 | 9 | 32295537 | ||
| Pubmed | 6.79e-07 | 346 | 99 | 9 | 14611657 | ||
| Pubmed | MARCH2 promotes endocytosis and lysosomal sorting of carvedilol-bound β(2)-adrenergic receptors. | 7.77e-07 | 7 | 99 | 3 | 23166351 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | RALGAPB LYST GSK3A NEDD4 PIK3R4 USP8 SSX2IP ZBTB21 AKAP13 CKAP2 ATP2B1 UTRN PCM1 | 1.04e-06 | 861 | 99 | 13 | 36931259 |
| Pubmed | An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior. | 1.24e-06 | 8 | 99 | 3 | 16051150 | |
| Pubmed | 7.94e-06 | 251 | 99 | 7 | 29778605 | ||
| Pubmed | Agonist-selective, receptor-specific interaction of human P2Y receptors with beta-arrestin-1 and -2. | 8.02e-06 | 2 | 99 | 2 | 18703513 | |
| Pubmed | Msd1/SSX2IP-dependent microtubule anchorage ensures spindle orientation and primary cilia formation. | 8.02e-06 | 2 | 99 | 2 | 24397932 | |
| Pubmed | Beta-arrestins 1 and 2 are associated with nicotine dependence in European American smokers. | 8.02e-06 | 2 | 99 | 2 | 17579607 | |
| Pubmed | Beta-arrestin 1 regulation of reward-motivated behaviors and glutamatergic function. | 8.02e-06 | 2 | 99 | 2 | 28973019 | |
| Pubmed | β-Arrestin1 enhances hepatocellular carcinogenesis through inflammation-mediated Akt signalling. | 8.02e-06 | 2 | 99 | 2 | 26077142 | |
| Pubmed | Beta-arrestin is a necessary component of Wnt/beta-catenin signaling in vitro and in vivo. | 8.02e-06 | 2 | 99 | 2 | 17426148 | |
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 34344831 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 21543334 | ||
| Pubmed | LSD-stimulated behaviors in mice require β-arrestin 2 but not β-arrestin 1. | 8.02e-06 | 2 | 99 | 2 | 34480046 | |
| Pubmed | ARRB2 (β-Arrestin-2) Deficiency Alters Fluid Homeostasis and Blood Pressure Regulation. | 8.02e-06 | 2 | 99 | 2 | 36215165 | |
| Pubmed | Critical regulation of CD4+ T cell survival and autoimmunity by beta-arrestin 1. | 8.02e-06 | 2 | 99 | 2 | 17618287 | |
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 26103985 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 34450275 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 9668034 | ||
| Pubmed | Metabolic effects of skeletal muscle-specific deletion of beta-arrestin-1 and -2 in mice. | 8.02e-06 | 2 | 99 | 2 | 31622341 | |
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 16181421 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 33836347 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 21855149 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 18519945 | ||
| Pubmed | Regulation of mitochondrial oxidative stress by β-arrestins in cultured human cardiac fibroblasts. | 8.02e-06 | 2 | 99 | 2 | 26449263 | |
| Pubmed | The role of beta-arrestins in the formyl peptide receptor-like 1 internalization and signaling. | 8.02e-06 | 2 | 99 | 2 | 17594911 | |
| Pubmed | Light-dependent regulation of the transcriptional activity of the mammalian gene for arrestin. | 8.02e-06 | 2 | 99 | 2 | 7932878 | |
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 12582207 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 26927499 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 22699970 | ||
| Pubmed | beta-Arrestin1 mediates nicotinic acid-induced flushing, but not its antilipolytic effect, in mice. | 8.02e-06 | 2 | 99 | 2 | 19349687 | |
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 21411739 | ||
| Pubmed | The Two β-Arrestins Regulate Distinct Metabolic Processes: Studies with Novel Mutant Mouse Models. | 8.02e-06 | 2 | 99 | 2 | 35008921 | |
| Pubmed | Deficiency of β-Arrestin 2 in Dendritic Cells Contributes to Autoimmune Diseases. | 8.02e-06 | 2 | 99 | 2 | 30541881 | |
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 25134464 | ||
| Pubmed | beta-Arrestin 1 and 2 differentially regulate heptahelical receptor signaling and trafficking. | 8.02e-06 | 2 | 99 | 2 | 11171997 | |
| Pubmed | Regulation of lipopolysaccharide-induced inflammatory response and endotoxemia by beta-arrestins. | 8.02e-06 | 2 | 99 | 2 | 20589830 | |
| Pubmed | β-Arrestin2 mediates the initiation and progression of myeloid leukemia. | 8.02e-06 | 2 | 99 | 2 | 22773819 | |
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 17418896 | ||
| Pubmed | β-Arrestin2 mediates progression of murine primary myelofibrosis. | 8.02e-06 | 2 | 99 | 2 | 29263312 | |
| Pubmed | β-Arrestins Regulate Stem Cell-Like Phenotype and Response to Chemotherapy in Bladder Cancer. | 8.02e-06 | 2 | 99 | 2 | 30787175 | |
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 19896992 | ||
| Pubmed | Unique Roles of β-Arrestin in GPCR Trafficking Revealed by Photoinducible Dimerizers. | 8.02e-06 | 2 | 99 | 2 | 29330504 | |
| Pubmed | β-Arrestins promote podocyte injury by inhibition of autophagy in diabetic nephropathy. | 8.02e-06 | 2 | 99 | 2 | 27054338 | |
| Pubmed | Transduction of group I mGluR-mediated synaptic plasticity by β-arrestin2 signalling. | 8.02e-06 | 2 | 99 | 2 | 27886171 | |
| Pubmed | Hepatic β-arrestin 2 is essential for maintaining euglycemia. | 8.02e-06 | 2 | 99 | 2 | 28650340 | |
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 8486659 | ||
| Pubmed | Scaffolding mechanism of arrestin-2 in the cRaf/MEK1/ERK signaling cascade. | 8.02e-06 | 2 | 99 | 2 | 34507982 | |
| Pubmed | β-arrestin expression in corticotroph tumor cells is modulated by glucocorticoids. | 8.02e-06 | 2 | 99 | 2 | 32027601 | |
| Pubmed | Arrestin-2 differentially regulates PAR4 and ADP receptor signaling in platelets. | 8.02e-06 | 2 | 99 | 2 | 21106537 | |
| Pubmed | β-arrestins negatively control human adrenomedullin type 1-receptor internalization. | 8.02e-06 | 2 | 99 | 2 | 28427767 | |
| Pubmed | 9.93e-06 | 15 | 99 | 3 | 23236378 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ST7 RALGAPB ADGRV1 TECTA PPARGC1B ARRB1 ARRB2 SMG7 AKAP13 PHF14 CKAP2 ATP2B1 UTRN KDM6A PCM1 | 2.03e-05 | 1489 | 99 | 15 | 28611215 |
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 18480058 | ||
| Pubmed | Beta-blockers alprenolol and carvedilol stimulate beta-arrestin-mediated EGFR transactivation. | 2.40e-05 | 3 | 99 | 2 | 18787115 | |
| Pubmed | Identification of receptor binding-induced conformational changes in non-visual arrestins. | 2.40e-05 | 3 | 99 | 2 | 24867953 | |
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 21130869 | ||
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 26211463 | ||
| Pubmed | β-Arrestin signal complex plays a critical role in adipose differentiation. | 2.40e-05 | 3 | 99 | 2 | 23557604 | |
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 19416857 | ||
| Pubmed | β-Arrestin1 and 2 differentially regulate PACAP-induced PAC1 receptor signaling and trafficking. | 2.40e-05 | 3 | 99 | 2 | 29734363 | |
| Pubmed | Essential requirement for β-arrestin2 in mouse intestinal tumors with elevated Wnt signaling. | 2.40e-05 | 3 | 99 | 2 | 22315403 | |
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 10549660 | ||
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 12538596 | ||
| Pubmed | Targeting of diacylglycerol degradation to M1 muscarinic receptors by beta-arrestins. | 2.40e-05 | 3 | 99 | 2 | 17272726 | |
| Pubmed | Beta-arrestins regulate a Ral-GDS Ral effector pathway that mediates cytoskeletal reorganization. | 2.40e-05 | 3 | 99 | 2 | 12105416 | |
| Pubmed | GSK3α phosphorylates dynamin-2 to promote GLUT4 endocytosis in muscle cells. | 2.40e-05 | 3 | 99 | 2 | 36445308 | |
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 21642958 | ||
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 27013682 | ||
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 28300069 | ||
| Pubmed | Beta-arrestin 2 is required for lysophosphatidic acid-induced NF-kappaB activation. | 2.40e-05 | 3 | 99 | 2 | 18952848 | |
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 20207744 | ||
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 25766502 | ||
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 16809338 | ||
| Pubmed | Promyogenic function of Integrin/FAK signaling is mediated by Cdo, Cdc42 and MyoD. | 2.40e-05 | 3 | 99 | 2 | 21397010 | |
| Pubmed | β-Arrestin2 is a critical component of the GPCR-eNOS signalosome. | 2.40e-05 | 3 | 99 | 2 | 32404425 | |
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 20801186 | ||
| Pubmed | The transient receptor potential vanilloid 4 channel modulates uterine tone during pregnancy. | 2.40e-05 | 3 | 99 | 2 | 26702092 | |
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 14500724 | ||
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 1458825 | ||
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 21700709 | ||
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 15173580 | ||
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 28062183 | ||
| Pubmed | Quantification of beta adrenergic receptor subtypes in beta-arrestin knockout mouse airways. | 2.40e-05 | 3 | 99 | 2 | 25658948 | |
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 25147978 | ||
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 28581517 | ||
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 24169548 | ||
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 23449980 | ||
| Pubmed | Beneficial metabolic role of β-arrestin-1 expressed by AgRP neurons. | 2.40e-05 | 3 | 99 | 2 | 32537493 | |
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 16580177 | ||
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 9169477 | ||
| Pubmed | Direct binding of beta-arrestins to two distinct intracellular domains of the delta opioid receptor. | 2.40e-05 | 3 | 99 | 2 | 11259507 | |
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 17525124 | ||
| Cytoband | 1q44 | 1.54e-07 | 110 | 99 | 6 | 1q44 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q44 | 3.78e-07 | 128 | 99 | 6 | chr1q44 | |
| Cytoband | 6q24 | 1.28e-04 | 8 | 99 | 2 | 6q24 | |
| GeneFamily | Olfactory receptors, family 2 | 5.37e-06 | 113 | 71 | 6 | 149 | |
| GeneFamily | Classical arrestins | 9.08e-05 | 4 | 71 | 2 | 1312 | |
| GeneFamily | Olfactory receptors, family 13 | 9.71e-05 | 23 | 71 | 3 | 162 | |
| GeneFamily | Olfactory receptors, family 14 | 3.15e-04 | 7 | 71 | 2 | 163 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-07 | 182 | 99 | 7 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-07 | 184 | 99 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-07 | 184 | 99 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-07 | 184 | 99 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-07 | 185 | 99 | 7 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-06 | 160 | 99 | 6 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-06 | 160 | 99 | 6 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-06 | 176 | 99 | 6 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.52e-06 | 184 | 99 | 6 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | NS-critical-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.24e-06 | 190 | 99 | 6 | 7be0f2ff86ca8500a43e0d44e5e292530f9ba0bb | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 5.53e-06 | 199 | 99 | 6 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | PND07-28-samps-Mesenchymal-Mesothelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.58e-05 | 156 | 99 | 5 | 574f761962a7dd3308bd41fc529dd3ea1b8625f8 | |
| ToppCell | PND07-28-samps-Mesenchymal-Mesothelial-Mesothelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.58e-05 | 156 | 99 | 5 | 605d95a900e1443d3f6aae163ef2e893d3293203 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.10e-05 | 162 | 99 | 5 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-stromal_related-ICC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.38e-05 | 165 | 99 | 5 | b1bbf5acdfc52bd8c7c7eb356d73b812eb6b908c | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-stromal_related|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.38e-05 | 165 | 99 | 5 | 28f8297ec7b781149cc7ac2f5e441771083b8ee3 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_SLITRK6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.79e-05 | 169 | 99 | 5 | 1c9e54e7b14eb99996590fb93b257cf881a9f184 | |
| ToppCell | Lymphoid-Lymphoid-T_cells_(Cd8+_T_cell)|Lymphoid / shred on cell class and cell subclass (v4) | 3.90e-05 | 170 | 99 | 5 | 20fd1a312c81c1bf3c5d2d6caf9b578e6b7a4171 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_NK|GI_small-bowel / Manually curated celltypes from each tissue | 4.35e-05 | 174 | 99 | 5 | 09b216f07cffd3ea2149ea95ffb5cd7219b3a98c | |
| ToppCell | facs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.47e-05 | 175 | 99 | 5 | 887e75fc90e59a6394d62f3c048a9cfdf6707725 | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 4.72e-05 | 177 | 99 | 5 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.85e-05 | 178 | 99 | 5 | c87945146b2734141f07b39d268e0d8086ee0364 | |
| ToppCell | Endothelial-A-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 5.12e-05 | 180 | 99 | 5 | 4c3376169770ee9f9283daae44c17f35e46bfd19 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_neutrophil-granulo-neutrophil-myelocyte|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.39e-05 | 182 | 99 | 5 | 52eac2f892ea7f26731e0b21c578fd2665a1657a | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.39e-05 | 182 | 99 | 5 | bc8d621be57f76d718d9b0f11e023b0f4dcb668d | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.68e-05 | 184 | 99 | 5 | 7d41784eac0935e77d6bc701f20c693adf998730 | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.82e-05 | 185 | 99 | 5 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.82e-05 | 185 | 99 | 5 | 70de48988c1f8e0809afc8092b663aa439d8e528 | |
| ToppCell | Control-Endothelial-VE_Capillary_A|World / Disease state, Lineage and Cell class | 5.82e-05 | 185 | 99 | 5 | a28187c2fd23564314b35759479ff2ca21f61485 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.98e-05 | 186 | 99 | 5 | 4d68ee3d32f7ef884faf402ef92b31b0eb4656f1 | |
| ToppCell | droplet-Spleen-nan-3m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.98e-05 | 186 | 99 | 5 | 26f1e9930adf2fe4af0819e56f69915bd8330e4a | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-Granular_Neuron_CB_Gabra6|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.98e-05 | 186 | 99 | 5 | d6c8ce2a32c218dcc63d861cc247152430ed3c8c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.13e-05 | 187 | 99 | 5 | f124d2c699b717b7c02a1a70493f515b83dc2f4c | |
| ToppCell | Control-Endothelial-VE_Capillary_A|Control / Disease state, Lineage and Cell class | 6.13e-05 | 187 | 99 | 5 | 54d7588172ac145ff5045ad9771636729ca3f0ca | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.44e-05 | 189 | 99 | 5 | e32172ad09e93f6ac6ea2b92145b2b73003f7970 | |
| ToppCell | Control-Endothelial-VE_Capillary_B|World / Disease state, Lineage and Cell class | 6.77e-05 | 191 | 99 | 5 | c672c8e28d06d555335976b3f8bd2ea6d3b34aae | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.94e-05 | 192 | 99 | 5 | 5b7093d5af5ae7b0e6d3a464cc56272440ecedad | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-stromal_related|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.94e-05 | 192 | 99 | 5 | 8ad6678df89175c5a4a835c8566f1552df3c996e | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-stromal_related-ICC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.94e-05 | 192 | 99 | 5 | 2f5378ea0b2fb2f672a36585d375f675983363a1 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-stromal_related|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.11e-05 | 193 | 99 | 5 | f27e2be497745098b5269aa799dd3d5f62d78ba7 | |
| ToppCell | Control-Fibroblasts-Vascular_smooth_muscle|Control / group, cell type (main and fine annotations) | 7.11e-05 | 193 | 99 | 5 | 60e44aac8be0430ad35e20eb98b1b700d76a0427 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-stromal_related-ICC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.11e-05 | 193 | 99 | 5 | 4ccf984baebbb13ae916727137ce593fda7514a2 | |
| ToppCell | LAM-Endothelial|LAM / Condition, Lineage and Cell class | 7.29e-05 | 194 | 99 | 5 | 1241e3e75414b619abc9431627619f5c194ec930 | |
| ToppCell | ASK440-Endothelial-Endothelium|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 7.47e-05 | 195 | 99 | 5 | 304f0dc91bb57e98b0ca31d6bfb3ff9364e4da56 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.47e-05 | 195 | 99 | 5 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.47e-05 | 195 | 99 | 5 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.65e-05 | 196 | 99 | 5 | b07db4a53ab9be9aad6fae5e45f9547db829d096 | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.65e-05 | 196 | 99 | 5 | 49cc0a2b9739abad61dff7292ea0b14d28ff35c4 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.65e-05 | 196 | 99 | 5 | 686533fd3fba8e4df96b9dd1307e870e89db4332 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.65e-05 | 196 | 99 | 5 | c366f980cc04abfe1c0c14746c11810c812a42c0 | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|lung / Disease (COVID-19 only), tissue and cell type | 7.65e-05 | 196 | 99 | 5 | 4ac4073380d939a73cec7413e9f3f5ef616d2924 | |
| ToppCell | T_cells-CTLs|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 7.84e-05 | 197 | 99 | 5 | 28117cf300e169182571fbad0de1681a484a435a | |
| ToppCell | nucseq-Endothelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.84e-05 | 197 | 99 | 5 | ebf9be068eaa658493fa7884fd19f34642922acb | |
| ToppCell | PCW_10-12|World / Celltypes from embryonic and fetal-stage human lung | 7.84e-05 | 197 | 99 | 5 | 47fd8b0d596c5db1a722473c8efbb17a6bbe7538 | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Endothelial-2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 8.22e-05 | 199 | 99 | 5 | edb68a4f622a494f22fd7b25bc40ae0d58456cdb | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-intermediate_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 8.22e-05 | 199 | 99 | 5 | f9e3fb974ba8fe1b6d99892577549ef143df9e08 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Endothelial-2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.22e-05 | 199 | 99 | 5 | 448dd5a27d57627468c6b8347f1b6b1005aea004 | |
| ToppCell | distal-2-Endothelial-Capillary_Aerocyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.22e-05 | 199 | 99 | 5 | bf70c8bfe932bccac5014e55f82019c5148627e7 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Endothelial-2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.22e-05 | 199 | 99 | 5 | 45f9c03d2ed2d98d66086fb0251bd24e30c6f775 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-MIR548F2--L5-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.41e-05 | 200 | 99 | 5 | 3cbb01039d1e7635ec4dcdf0223587f7ea3c7b34 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-MIR548F2-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.41e-05 | 200 | 99 | 5 | 97a010a1b6d551239cf6ea5a43319fb413ff180e | |
| ToppCell | distal-2-Endothelial-Capillary|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.41e-05 | 200 | 99 | 5 | 8daf09d63c2fda6da6e5b66f96e7449ee8b17029 | |
| ToppCell | distal-1-Endothelial|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.41e-05 | 200 | 99 | 5 | 8f25b27c10e89cf9d0091bd53c24ce63ed7d6222 | |
| ToppCell | distal-Endothelial-Capillary|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.41e-05 | 200 | 99 | 5 | 0ee29b2bd9cd3a1c80e0535017814f752c3eb1fa | |
| ToppCell | distal-Endothelial|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.41e-05 | 200 | 99 | 5 | b17c9607d4986f8f1facc6b564d4c15c48e58915 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-MIR548F2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.41e-05 | 200 | 99 | 5 | 8ccf2dbbe34b26fbf2bbef1e64b4ae636edd6672 | |
| ToppCell | Neuronal-Excitatory-eE(FEZF2_SLC17A7)-eE_2-SCUBE1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.41e-05 | 200 | 99 | 5 | 012dd2180f6f596d6e55e864be2e62b53c15edb2 | |
| ToppCell | Parenchymal-10x3prime_v2-Endothelial-Endothelia_vascular|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 8.41e-05 | 200 | 99 | 5 | 6567683f8f534310fecb44a6721909183fdc15ca | |
| ToppCell | Parenchymal-10x3prime_v2-Endothelial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 8.41e-05 | 200 | 99 | 5 | 3b07cf1a4dff2e868f52382681a2030c1248caed | |
| ToppCell | Neuronal-Excitatory-eE(FEZF2_SLC17A7)-eE_2-SCUBE1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.41e-05 | 200 | 99 | 5 | 06f949c81eecba00203f0716d0c5854724871184 | |
| ToppCell | Neuronal-Excitatory-eE(FEZF2_SLC17A7)-eE_2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.41e-05 | 200 | 99 | 5 | d31e26387d879ee30731c497cea6aaf4746e40d9 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.41e-05 | 200 | 99 | 5 | 105c67e4f5eff036013d655c8e8ac577d32dae2e | |
| ToppCell | Neuronal-Excitatory-eE(FEZF2_SLC17A7)-eE_2-SCUBE1--L6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.41e-05 | 200 | 99 | 5 | 57e8aea2c2f736ce37940dceb36224552dc33da1 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac2_Myh4|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.97e-04 | 129 | 99 | 4 | f83187c0bb06528127b8d2d56674ab1946846951 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Granulocytic-Neutrophil|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.99e-04 | 144 | 99 | 4 | 1efa434e577d1f87e02df01667782f414d63bd60 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Granulocytic-Neutrophil-Neutrophil_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.99e-04 | 144 | 99 | 4 | c0c5f254a960ba5e5f1354599d54e77360e6c2ac | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.15e-04 | 146 | 99 | 4 | 2ac9b487a7991fdc15444aeb93533030e09825bb | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Glra3|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.24e-04 | 147 | 99 | 4 | 50e86860a94be103092c40e39a172eac92372f0d | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Hpse_Sema3c|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.96e-04 | 155 | 99 | 4 | 5c7b68b59244525e3714806c205a57a2daebf423 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Myh8_Fibin|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.15e-04 | 157 | 99 | 4 | 741d79c10cb87fa7f14080c6fccb1553c3a20bad | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Glra3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.46e-04 | 160 | 99 | 4 | 0bfdaf979e6f128cba2928ce16bca4d3deff8ac9 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.46e-04 | 160 | 99 | 4 | 8bcdbcfdf1e0ace6053e8de82762f6e2f86bba7a | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Type_1_alveolar|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.46e-04 | 160 | 99 | 4 | 58ed3a074932ccc951e07868dfdc61b99ae1cc2b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.46e-04 | 160 | 99 | 4 | 2d391ba6f7adb55dfa89feecc10cc9ce97e5fe74 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.57e-04 | 161 | 99 | 4 | dccb61d5e17a8f1c6d1fc146ee389f567659a0f0 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Ctxn3_Sla|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.67e-04 | 162 | 99 | 4 | 4d13c271b4f63cf32980e5643b5d5951165fe8b5 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.78e-04 | 163 | 99 | 4 | 1e8ab00ecc2d2ba35aa6745c0ed38663e26312e8 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L4-L4_IT_VISp_Rspo1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.78e-04 | 163 | 99 | 4 | 431221a41d396b09170476179590eaf8a55266d8 | |
| ToppCell | TCGA-Uterus-Primary_Tumor-Uterine_Carcinoma-Uterine_Carcinosarcoma-3|TCGA-Uterus / Sample_Type by Project: Shred V9 | 4.78e-04 | 163 | 99 | 4 | d64dd39b077105c73e570ccef70f0e74a2c586ac | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid-Myeloid_Dendritic_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.01e-04 | 165 | 99 | 4 | 2477b0f1a0ea26184cf3cc4a9ffcdfa825cbc615 | |
| ToppCell | facs-Large_Intestine-Proximal-24m-Epithelial-Enterocyte_(Proximal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.01e-04 | 165 | 99 | 4 | ce79d217df88035457cd58f679e72dd98722ae22 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_TBCC|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.01e-04 | 165 | 99 | 4 | 7978eefcfc40175e933f7a8b64a5dd1c661dd1ac | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-Granular_Neuron_CB_Gabra6|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.12e-04 | 166 | 99 | 4 | ec7bd549bda5f18aca8aebce5ba479a81abbbeda | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_SLITRK6|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.12e-04 | 166 | 99 | 4 | a907d39ca5cf023de633fe5f2b28759b7af4eebc | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-Enterocyte_(Proximal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.12e-04 | 166 | 99 | 4 | 22b31acbbef1936ce19b393cf880c63ea2fa0f1b | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_104|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.12e-04 | 166 | 99 | 4 | c11dcf9705b85ac3da6ae86358f5ffd64ae8327e | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic-DN4|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.24e-04 | 167 | 99 | 4 | 10c9fab3573c2948081aac2cec1798e46e59e38a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.24e-04 | 167 | 99 | 4 | a6ff7a3d9b80839c0efa91658836812e868561fa | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.24e-04 | 167 | 99 | 4 | 3dfec2fcc36caa6e394efae5e540a6fa28759977 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.24e-04 | 167 | 99 | 4 | 95b3b5ba3414729f0460a26a0deca48de0cbe33e | |
| Disease | Unipolar Depression | 2.07e-04 | 259 | 96 | 6 | C0041696 | |
| Disease | Depressive disorder | 3.71e-04 | 289 | 96 | 6 | C0011581 | |
| Disease | response to beta blocker | 4.29e-04 | 45 | 96 | 3 | EFO_0007766 | |
| Disease | maleate measurement, Alpha ketoglutarate measurement, fumarate measurement | 5.65e-04 | 11 | 96 | 2 | EFO_0010457, EFO_0010480, EFO_0010509 | |
| Disease | middle temporal gyrus volume measurement | 5.65e-04 | 11 | 96 | 2 | EFO_0010316 | |
| Disease | Epilepsy, Cryptogenic | 2.45e-03 | 82 | 96 | 3 | C0086237 | |
| Disease | Awakening Epilepsy | 2.45e-03 | 82 | 96 | 3 | C0751111 | |
| Disease | Aura | 2.45e-03 | 82 | 96 | 3 | C0236018 | |
| Disease | thalamus volume | 2.72e-03 | 85 | 96 | 3 | EFO_0006935 | |
| Disease | peptic ulcer disease, Peptic ulcer and gastro-oesophageal reflux disease (GORD) drug use measurement, gastroesophageal reflux disease | 2.76e-03 | 24 | 96 | 2 | EFO_0003948, EFO_0009923, MONDO_0004247 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LCISLSSSAYIAVPT | 66 | Q9N2J8 | |
| SSLYSQQVLCSSIPL | 31 | Q9Y2D8 | |
| QSSPTVSSTCTKVLY | 591 | Q155Q3 | |
| TPYSSKLLKSCLETV | 261 | Q96GX5 | |
| YCTSAISSPLTKSIS | 1676 | Q12802 | |
| SKTILDSCPYLSILA | 5736 | Q8WXG9 | |
| YLPGLQSCQKSVSST | 61 | P0DMQ9 | |
| SRPQYKTSCGISSLI | 206 | Q86UB2 | |
| PERYISSSCVLTSIL | 51 | Q5T3Y7 | |
| TVAPSSTFCKVYTLT | 261 | P49407 | |
| SSTFCKVYTITPLLS | 266 | P32121 | |
| TGISVNCAYTSKILP | 516 | P20020 | |
| TITSPRLAALTYKCT | 1036 | Q8TE56 | |
| TSCLIKYNVSTTPYL | 586 | Q8WWK9 | |
| ACSYFTSNALPLKIT | 891 | O75747 | |
| LTPGEVYNLATCSTK | 386 | Q15818 | |
| LSLLDACYTSVITPQ | 66 | Q8NGQ6 | |
| ACYTSVITPQILATL | 71 | Q8NGQ6 | |
| ICYTTSSIPSTLVSL | 71 | Q8NGS5 | |
| PTSLCTLLSKGSYQT | 281 | P46934 | |
| VLSCLVAISSLTYLP | 121 | Q15012 | |
| SVSIYPSSAEVLKAC | 886 | O15550 | |
| TLSCLLQTLLTGPYS | 1026 | Q15154 | |
| LNYTVLIGSTPCTLT | 1186 | Q9UIW2 | |
| YISVTVPTSCVNSLL | 71 | Q8NHC7 | |
| TSITCHNILSLPKYS | 981 | Q8IVU3 | |
| ACYLKISQILTTSPS | 881 | P59047 | |
| KTCLLISYTTNKFPS | 16 | P60953 | |
| VPALLKLSCTDTSAY | 181 | Q8NH04 | |
| TPALLKLSCSDVSLY | 186 | Q8NGX1 | |
| TPALLKLSCSDVSLY | 186 | Q8NH03 | |
| ILPLLQLSCTSTYVN | 181 | Q8NGG8 | |
| PLVLKTLACTHSSAY | 1321 | Q8NDA8 | |
| INTVRQCTSKLSSYP | 436 | P50570 | |
| QSPTCYKQSTKLLGL | 1251 | A2RRP1 | |
| QKTSTLPAVLYSCGI | 716 | O94880 | |
| LLSPYIGNLSCIIST | 276 | Q7Z442 | |
| VPAVLKLSCSDTSLY | 181 | Q8NGZ9 | |
| TLLACVNSSSKPLIY | 236 | Q86SM5 | |
| AYVPSLALSTLNSCV | 321 | Q96RI0 | |
| AICSPLLYSTKMSTQ | 121 | Q8WZ92 | |
| ISPVTSTYCLSPRQK | 326 | Q5TID7 | |
| YSVSAAKLLALTPVC | 431 | Q05DH4 | |
| LNLIRYTATTKCSPS | 291 | Q8NFZ0 | |
| NVTLKSSPDLLTYFC | 86 | Q6UX52 | |
| AIALCSSLLEYTPSS | 376 | P49840 | |
| LVQYLATVCPLTSTL | 266 | Q8IW35 | |
| LTILCSSVSSDLAPY | 16 | Q4KMG0 | |
| YVLSFCKSASIPLTV | 321 | Q9NQR9 | |
| TFSCIRSYSSIVLKP | 681 | O94769 | |
| SLFVCKPYSILISVS | 3621 | Q99698 | |
| SLLCSPCKTTYSGSL | 86 | Q52LG2 | |
| STTKAPCILLYISSF | 1056 | Q9UHC6 | |
| KPLISYVGDSTVLTC | 166 | Q6PCB8 | |
| TPLTDRCYITLTQSL | 1846 | Q9NYC9 | |
| LKRYQSSALTVCSEP | 206 | O00321 | |
| FTLIAKPTTTSCYLQ | 646 | Q13255 | |
| SALSSCSTVLPLYHK | 186 | P21453 | |
| LSLLDLCYTTSTVPQ | 66 | Q9GZK3 | |
| ICYTSSSVPSTLVSL | 101 | Q8NGS6 | |
| PLLLLSCSSTYVNGV | 201 | Q8NGR1 | |
| ILPLLQLSCTSTYVN | 181 | Q96RD0 | |
| ICYTSASVPTLLVNL | 71 | Q8NGT1 | |
| IPSTEGQSKAYSICL | 226 | Q8NHC5 | |
| SICPSPLSTSTYVLQ | 191 | O00167 | |
| LCTVTSQPASGYLEK | 1106 | P0C091 | |
| LLSVPDVINCLTTTY | 2901 | P46939 | |
| SSLLPSCYSTKDTVV | 426 | Q2M3C7 | |
| PTTSLSAIIRTPKCY | 1741 | Q9P212 | |
| LNYPFSTSVKLSTGC | 146 | O95084 | |
| TSAIVKPQSSSCSYI | 136 | Q92540 | |
| LPVLSTLQLYCSSAL | 1346 | Q96Q15 | |
| LQKLLLATSYPTSSS | 156 | Q86YN6 | |
| TSLNSADLLKSLCYP | 391 | Q9Y623 | |
| KSVLTNYRFPSSLCV | 61 | Q9NTN3 | |
| ISLPKSATICYTAAL | 361 | Q9NRC1 | |
| TPYSLQVTLTLVCLA | 41 | P08913 | |
| LLSLSVKSSVYGPCT | 371 | Q8IZF4 | |
| VTLLKCLLIPTYHST | 21 | Q9BVK2 | |
| TYSPKVYSVNCSSLL | 256 | Q6ZU45 | |
| STILPSTYQIRITTC | 926 | Q99570 | |
| THLILTLNKCYATPT | 1971 | O75443 | |
| TYICLSVTNKKPTQA | 46 | Q8NFX7 | |
| SVCSSSETPYLLKET | 281 | Q9ULJ3 | |
| LLTSVLTTALKCSYL | 491 | Q7Z392 | |
| CLYQTLDNPLSKLTT | 226 | Q9BX84 | |
| ASRETYLVPSSCKSI | 106 | Q9HAI6 | |
| AQSCYLLTKTAVSRP | 131 | Q8IV42 | |
| VIQTKSTQCLSYPLT | 151 | Q9BRV3 | |
| STQCLSYPLTIATLL | 156 | Q9BRV3 | |
| KETIYPHLLCSTSVQ | 301 | Q3MJ13 | |
| IPKSLSLSSYCNEST | 531 | Q9HBJ7 | |
| SICLPLLSVYQLSTN | 1361 | Q5SRE5 | |
| TPLLCLVSYASLVAT | 136 | Q6XQN6 | |
| SLERYTPTTTQLSCK | 791 | Q6UXZ4 | |
| SPCSLVNETTLIKYS | 921 | Q86X10 | |
| TKYISDGQCTSISPL | 81 | Q6X4U4 | |
| NYPLSAALTCAKLTT | 221 | Q92979 | |
| VNVSLQCLTYTLPLS | 91 | P0C7H9 | |
| SNIPCLSKLLYIALS | 1061 | Q5SVZ6 | |
| SFSTLPRLKTYLCNT | 1086 | Q5SVZ6 | |
| YLSLPLASTSKCTLQ | 951 | P40818 | |
| LTLKSLQLYVCSVTP | 681 | Q9ULE0 | |
| CYETLSKTNPSVSSL | 1011 | P57678 |